STOCK TITAN

[Form 4] Enovis Corporation Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Insider purchase by Enovis executive: Tandy Bradley J, SVP and Chief Legal Officer of Enovis Corporation (ENOV), reported purchasing 3,200 shares of Enovis common stock on 08/22/2025 at a price of $31.41 per share. After the transaction, Mr. Bradley beneficially owned 43,515 shares. The Form 4 was signed via attorney-in-fact on 08/25/2025.

Acquisto da parte di un dirigente di Enovis: Tandy Bradley J, SVP e Chief Legal Officer di Enovis Corporation (ENOV), ha riferito l'acquisto di 3.200 azioni ordinarie di Enovis il 22/08/2025 al prezzo di $31,41 per azione. Dopo la transazione, il Sig. Bradley risultava titolare effettivo di 43.515 azioni. Il Modulo 4 è stato firmato per procura il 25/08/2025.

Compra de un directivo de Enovis: Tandy Bradley J, SVP y Chief Legal Officer de Enovis Corporation (ENOV), comunicó la compra de 3.200 acciones ordinarias de Enovis el 22/08/2025 a un precio de $31,41 por acción. Tras la operación, el Sr. Bradley poseía de forma beneficial 43.515 acciones. El Formulario 4 fue firmado mediante apoderado el 25/08/2025.

Enovis 임원 내부자 매수: Enovis Corporation(ENOV)의 SVP 겸 법무책임자 Tandy Bradley J는 2025-08-22에 주당 $31.41에 Enovis 보통주 3,200주를 매수했다고 보고했습니다. 거래 후 Bradley 씨는 43,515주를 실질 보유하고 있었습니다. Form 4는 2025-08-25에 대리인(법정대리인)에 의해 서명되었습니다.

Achat par un dirigeant d'Enovis : Tandy Bradley J, SVP et Chief Legal Officer d'Enovis Corporation (ENOV), a déclaré l'achat de 3 200 actions ordinaires Enovis le 22/08/2025 au prix de 31,41 $ par action. Après la transaction, M. Bradley détenait de manière bénéficiaire 43 515 actions. Le formulaire 4 a été signé par mandataire le 25/08/2025.

Insider-Kauf durch Enovis-Manager: Tandy Bradley J, SVP und Chief Legal Officer der Enovis Corporation (ENOV), meldete den Kauf von 3.200 Stammaktien von Enovis am 22.08.2025 zum Preis von $31,41 pro Aktie. Nach der Transaktion besaß Herr Bradley wirtschaftlich 43.515 Aktien. Das Formular 4 wurde am 25.08.2025 durch einen Bevollmächtigten unterzeichnet.

Positive
  • Insider purchase reported: SVP and Chief Legal Officer acquired 3,200 shares at $31.41, raising beneficial ownership to 43,515 shares
  • Timely disclosure: Form 4 filed and signed (via attorney-in-fact) within days of the transaction
Negative
  • None.

Insights

TL;DR: An insider bought 3,200 shares at $31.41, modestly increasing insider ownership—generally a mild positive signal about executive confidence.

The purchase by the SVP and Chief Legal Officer increases his beneficial holdings to 43,515 shares. The transaction size is relatively small versus typical market-capitalization scales, so its market-moving potential is limited, but insider purchases often receive positive attention from investors as a sign of management confidence.

TL;DR: Transaction is routine and properly reported; timing and use of an attorney-in-fact indicate compliant disclosure practices.

The Form 4 discloses a purchase under code "P" on 08/22/2025 and was filed with a signature by an attorney-in-fact on 08/25/2025. There is no other information about a trading plan or related parties. From a governance perspective, the filing appears complete and conforms to Section 16 reporting requirements.

Acquisto da parte di un dirigente di Enovis: Tandy Bradley J, SVP e Chief Legal Officer di Enovis Corporation (ENOV), ha riferito l'acquisto di 3.200 azioni ordinarie di Enovis il 22/08/2025 al prezzo di $31,41 per azione. Dopo la transazione, il Sig. Bradley risultava titolare effettivo di 43.515 azioni. Il Modulo 4 è stato firmato per procura il 25/08/2025.

Compra de un directivo de Enovis: Tandy Bradley J, SVP y Chief Legal Officer de Enovis Corporation (ENOV), comunicó la compra de 3.200 acciones ordinarias de Enovis el 22/08/2025 a un precio de $31,41 por acción. Tras la operación, el Sr. Bradley poseía de forma beneficial 43.515 acciones. El Formulario 4 fue firmado mediante apoderado el 25/08/2025.

Enovis 임원 내부자 매수: Enovis Corporation(ENOV)의 SVP 겸 법무책임자 Tandy Bradley J는 2025-08-22에 주당 $31.41에 Enovis 보통주 3,200주를 매수했다고 보고했습니다. 거래 후 Bradley 씨는 43,515주를 실질 보유하고 있었습니다. Form 4는 2025-08-25에 대리인(법정대리인)에 의해 서명되었습니다.

Achat par un dirigeant d'Enovis : Tandy Bradley J, SVP et Chief Legal Officer d'Enovis Corporation (ENOV), a déclaré l'achat de 3 200 actions ordinaires Enovis le 22/08/2025 au prix de 31,41 $ par action. Après la transaction, M. Bradley détenait de manière bénéficiaire 43 515 actions. Le formulaire 4 a été signé par mandataire le 25/08/2025.

Insider-Kauf durch Enovis-Manager: Tandy Bradley J, SVP und Chief Legal Officer der Enovis Corporation (ENOV), meldete den Kauf von 3.200 Stammaktien von Enovis am 22.08.2025 zum Preis von $31,41 pro Aktie. Nach der Transaktion besaß Herr Bradley wirtschaftlich 43.515 Aktien. Das Formular 4 wurde am 25.08.2025 durch einen Bevollmächtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Tandy Bradley J

(Last) (First) (Middle)
2711 CENTERVILLE ROAD
SUITE 400

(Street)
WILMINGTON DE 19808

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Enovis CORP [ ENOV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP and Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.001 08/22/2025 P 3,200 A $31.41 43,515 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Brian P. Hanigan, attorney-in-fact 08/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Enovis (ENOV) report?

Tandy Bradley J, SVP and Chief Legal Officer, purchased 3,200 shares of Enovis common stock on 08/22/2025 at $31.41 per share.

How many Enovis shares does the reporting person own after the transaction?

Following the purchase the reporting person beneficially owned 43,515 shares according to the Form 4.

When was the Form 4 for the ENOV transaction filed and signed?

The transaction date was 08/22/2025 and the Form 4 shows a signature by an attorney-in-fact dated 08/25/2025.

What transaction code was used on the Form 4 for ENOV?

The Form 4 lists transaction code P, indicating a purchase of shares.

Does the filing disclose any derivative transactions or additional securities?

No. Table II for derivative securities contains no entries; only the non-derivative purchase is reported.
Enovis Corp

NYSE:ENOV

ENOV Rankings

ENOV Latest News

ENOV Latest SEC Filings

ENOV Stock Data

1.80B
56.26M
1.56%
121.27%
12.03%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WILMINGTON